Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Antiretroviral Therapy
100%
Cancer Risk
100%
SMART Study
100%
Non-AIDS-defining Malignancies
100%
CD4 T Cells
55%
Malignancy Rate
33%
HIV RNA Levels
22%
Viral Suppression
22%
Lung
11%
Opportunistic Infections
11%
Hepatitis C
11%
Lymphoma
11%
Kaposi Sarcoma
11%
Prostate
11%
High Risk
11%
Cigarette Use
11%
Treatment Duration
11%
Randomized Clinical Trial
11%
Hepatitis B
11%
Hodgkin
11%
Treatment Group
11%
Baseline Characteristics
11%
Cox Model
11%
Non-Hodgkin
11%
Therapy Strategy
11%
Previous Malignancy
11%
Medicine and Dentistry
Cancer
100%
Antiretroviral Therapy
100%
Acquired Immune Deficiency Syndrome
76%
T-Helper Cell
38%
Arm
38%
Human Immunodeficiency Virus
15%
Malignant Neoplasm
7%
Lung
7%
Kaposi Sarcoma
7%
Opportunistic Infection
7%
Hepatitis C
7%
Hodgkin's Lymphoma
7%
Hepatitis B
7%
Proportional Hazards Model
7%
Cell Count
7%
Treatment Duration
7%
Treatment Group
7%
Randomized Clinical Trials
7%
Immunology and Microbiology
Acquired Immune Deficiency Syndrome
100%
Arm
50%
T-Helper Cell
40%
Human Immunodeficiency Virus
20%
Ribonucleic Acid
20%
Lung
10%
CD4 Lymphocyte Count
10%
Hepatitis C
10%
Hepatitis B
10%
Opportunistic Infection
10%
Pharmacology, Toxicology and Pharmaceutical Science
Acquired Immune Deficiency Syndrome
100%
HIV
20%
Randomized Clinical Trial
10%
Malignant Neoplasm
10%
Opportunistic Infection
10%
Hodgkin Disease
10%
Hepatitis B
10%
Kaposi Sarcoma
10%
Hepatitis C
10%
Treatment Group
10%